
Twelve years of multiples investors have paid for Privi Speciality Chemicals Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Privi Speciality Chemicals Ltd trades at a P/E of 41.28× and P/B of 9.55×.
Twelve years of audited numbers for Privi Speciality Chemicals Ltd, switchable between annual and quarterly views, consolidated or standalone.
Privi Speciality Chemicals Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹13,554.37 Cr and reported EPS of ₹83.70.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,040 | 1,341 | 1,631 | 1,277 | 1,404 | 1,608 | 1,752 | 2,101 | 2,564 |
| Other Income | 16 | 6 | 27 | 20 | 32 | 21 | 26 | 21 | 19 |
| Total Income | 1,056 | 1,347 | 1,657 | 1,297 | 1,436 | 1,629 | 1,779 | 2,122 | 2,583 |
| Cost of Goods Sold (COGS) | 663 | 827 | 1,008 | 751 | 831 | 961 | 1,009 | 1,131 | 1,317 |
| Gross Profit | 377 | 514 | 623 | 525 | 573 | 647 | 743 | 970 | 1,247 |
| +Operating Expenses | 247 | 301 | 355 | 318 | 379 | 461 | 418 | 516 | 600 |
| EBITDA | 130 | 213 | 268 | 208 | 194 | 186 | 325 | 454 | 646 |
| +Non-Operating Expenses | 67 | 85 | 143 | 116 | 104 | 176 | 221 | 220 | 226 |
| Profit Before Tax (PBT) | 79 | 152 | 231 | 158 | 133 | 31 | 130 | 255 | 440 |
| +Tax Expense | 26 | 57 | 55 | 41 | 35 | 10 | 34 | 70 | 123 |
| Profit After Tax (PAT) | 53 | 94 | 176 | 117 | 97 | 21 | 95 | 185 | 317 |
| Earnings Per Share (EPS) | 14.18 | 24.13 | 45.14 | 29.93 | 24.93 | 5.69 | 24.43 | 47.30 | 81.08 |
| Diluted Shares Outstanding (Nos.) | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| +Additional Disclosures | 1,639 | 2,031 | 2,474 | 1,912 | 2,140 | 2,561 | 2,658 | 2,999 | 3,461 |
| Sales Growth % | — | 29.01 | 21.59 | -21.71 | 9.96 | 14.54 | 8.98 | 19.91 | 22.01 |
| YoY Sales Growth % | — | 29.01 | 21.59 | -21.71 | 9.96 | 14.54 | 8.98 | 19.91 | 22.01 |
| Material Cost % | 61 | 69 | 62 | 61 | 72 | 71 | 54 | 56 | 53 |
| Employee Cost % | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 |
| Other Cost % | 18 | 17 | 17 | 19 | 22 | 24 | 20 | 20 | 19 |
| OPM % | 13 | 16 | 16 | 16 | 14 | 12 | 19 | 22 | 25 |
| Tax % | 32 | 38 | 24 | 26 | 27 | 31 | 27 | 27 | 28 |
| Profit Growth % | — | 76.69 | 87.10 | -33.70 | -16.70 | -78.15 | 348.49 | 93.60 | 71.43 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 87 | 166 | 205 | 137 | 119 | 77 | 202 | 322 | 502 |
Disclosed business segments at Privi Speciality Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Privi Speciality Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Privi Speciality Chemicals Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Privi Speciality Chemicals Ltd's investment case rests on 8 positive markers and 10 flagged concerns drawn from the latest reported filings.
Robust quarterly net profit growth of 97.40% signals strong performance.
Healthy ROE of 10.61% and ROCE of 16.40% demonstrate efficient capital use.
Consistent revenue growth. 14.39% (3Y) and 9.68% (5Y) CAGR.
High promoter holding at 69.9% indicates strong insider confidence.
Favorable PEG ratio of 0.50 suggests potential undervaluation relative to growth.
Elevated debt-to-equity ratio of 1.04 indicates higher financial leverage.
High P/E ratio of 59.49 suggests a premium valuation, limiting upside.
Negative cash flow per share (-4.61) raises liquidity and operational concerns.
Significant stock price volatility, with a 52-week range from 1352 to 2950.
Promoter shareholding declined from 74.05% to 69.89%, signaling potential dilution.
Trim if P/E re-rates above 54. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 71.39. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 20%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Privi Speciality Chemicals Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Privi Speciality Chemicals Ltd — derived from the live tape, not yesterday's close.
Privi Speciality Chemicals Ltd last traded at ₹3,469.1 with an intraday range of ₹3,461–₹3,529 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 3647.73 | +178.63 | +5.15% |
| R3 | 3579.73 | +110.63 | +3.19% |
| R2 | 3554.37 | +85.27 | +2.46% |
| R1 | 3511.73 | +42.63 | +1.23% |
| PIVOT | 3486.37 | 17.27 | 0.50% |
| CURRENT | 3469.10 | — | — |
| S1 | 3307.73 | -161.37 | -4.65% |
| S2 | 3375.73 | -93.37 | -2.69% |
| S3 | 3418.37 | -50.73 | -1.46% |
| S4 | 3443.73 | -25.37 | -0.73% |
PRIVISCL is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 3475 ~ 3502
Trading Above opening range, showing Bullishness
Daily traded volume and delivery percentage for Privi Speciality Chemicals Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Privi Speciality Chemicals Ltd stood at 56.6% of traded volume, against a 20-day average of 59.5%.
Filings Privi Speciality Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Privi Speciality Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 115 documents below.
Bhaktavatsala Doppalapudi Rao has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Privi Speciality Chemicals Limited has informed the Exchange about Schedule of meet
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Every dividend, stock split and bonus issue Privi Speciality Chemicals has declared, sequenced by announce and record date.
Privi Speciality Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Privi Speciality Chemicals Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Privi Speciality Chemicals Ltd operates in the Basic Materials, listed as NSE: PRIVISCL, BSE: 530117.

Privi Speciality Chemicals Limited (formerly Fairchem Speciality Limited) is a global manufacturer, supplier, and exporter of aroma and fragrance chemicals. Established in 1985 and headquartered in Mumbai, India, the company operates across a wide range of international markets including North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom.
Their product portfolio encompasses a broad spectrum of aroma and fragrance chemicals, categorized into several key groups. These include acetates, dihydromyrcenol, ionones, nitriles, sandalwood derivatives, and other specialty chemicals. They offer both bulk aroma chemicals and a comprehensive selection of individual aroma chemicals, with a particularly extensive range of terpenes and terpene derivatives.
The company's detailed catalog includes a wide array of specific aroma chemicals, such as alpha damascone, alpha ionone, alpha terpenyl acetate, various forms of amber, beta iso damascol, different grades of BI, carene, cedar ketol, citronellal, citronellyl acetate, citronellyl nitrile, dipentene, various turpentine oils, dihydro myrcenol, dihydromyrcene, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, various ionones, iso boronyl acetate, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTBCHA, rose oxide, multiple terpeniols, terpinolene, and several sandal-based products. Further expanding their offerings, they also supply cineol, trimethyl cyclohexyl methanol, cyclamen aldehyde, indomeran, floravane, ambo woody extreme, camphor, and iso berneol commercial.
In summary, Privi Speciality Chemicals Limited holds a significant position in the global aroma and fragrance chemical market, providing a diverse and extensive range of products to a global clientele. Their long history and international reach demonstrate their established presence and continued success within the industry.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Privi Speciality Chemicals Ltd (PRIVISCL) is ₹3,469.1. Today, the stock has gained by ₹24.80 (0.72%), trading in a range of ₹3,461 to ₹3,529. The stock opened at ₹3,500 with a trading volume of 1,69,830 shares.
Privi Speciality Chemicals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹13,554.37 crores, P/E ratio of 41.28, ROE of 24.76%, and ROCE of 16.40%. The dividend yield stands at 0.29%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Privi Speciality Chemicals Ltd (PRIVISCL) is ₹3,590.9, while the 52-week low is ₹2,050. Currently trading at ₹3,469.1, the stock is 92.1% away from its 52-week low and 3.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Privi Speciality Chemicals Ltd stock at ₹3,469.1 depends on multiple factors. The stock is currently trading with a P/E ratio of 41.28 and P/B ratio of 9.55. Today's performance shows a gain of 0.72%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Privi Speciality Chemicals Ltd offers a dividend yield of 0.29%, which means for every ₹100 invested at the current price of ₹3,469.1, you can expect to receive approximately ₹0.29 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Privi Speciality Chemicals Ltd's key financial metrics include: P/E Ratio: 41.28, P/B Ratio: 9.55, ROE: 24.76%, ROCE: 16.40%, Dividend Yield: 0.29%, EPS: ₹83.70, Book Value: ₹361.63, and Debt-to-Equity: 70.89. The company's market cap stands at ₹13,554.37 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Privi Speciality Chemicals Ltd stock opened at ₹3,500 and is currently trading at ₹3,469.1, showing a gain of ₹24.80 (0.72%). The intraday high is ₹3,529 and low is ₹3,461. The trading volume stands at 1,69,830 shares, indicating moderate market participation today.
Privi Speciality Chemicals Ltd has a Price-to-Earnings (P/E) ratio of 41.28, which means investors are willing to pay ₹41.28 for every ₹1 of earnings. With an EPS of ₹83.70, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Privi Speciality Chemicals Ltd (PRIVISCL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.